NCT02551705 Functional Imaging of Social Cognition in Premanifest Huntington's Disease Status UNKNOWN Phase NA
NCT02550275 Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging Status COMPLETED Phase NA
NCT02519036 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02509793 A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine) Status UNKNOWN Phase PHASE4
NCT02507284 Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease Status COMPLETED Phase PHASE2
NCT02494778 A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease Status TERMINATED Phase PHASE2
NCT02481674 A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi Status COMPLETED Phase PHASE2
NCT02418546 Electronic-health Application To Measure Outcomes REmotely Clinical Trial Status COMPLETED Phase NA
NCT02342548 Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021 Status TERMINATED Phase PHASE2
NCT02263430 PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease Status UNKNOWN Phase NA
NCT02252380 ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders Status ACTIVE_NOT_RECRUITING Phase NA
NCT02231580 Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients Status TERMINATED Phase PHASE2
NCT02215616 A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod Status COMPLETED Phase PHASE2
NCT02208934 Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers Status COMPLETED Phase PHASE1
NCT02197130 Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease Status COMPLETED Phase PHASE2
NCT02101957 Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103) Status UNKNOWN Phase PHASE2/PHASE3
NCT02074410 Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease Status TERMINATED Phase PHASE2
NCT02061722 [PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET. Status COMPLETED Phase EARLY_PHASE1
NCT02006472 A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease Status COMPLETED Phase PHASE2